BSGM — Biosig Technologies Cashflow Statement
0.000.00%
Last trade - 00:00- $1.04bn
- $1.04bn
- $0.04m
Annual cashflow statement for Biosig Technologies, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -59.1 | -32.9 | -27.3 | -28.7 | -10.3 |
| Depreciation | |||||
| Non-Cash Items | 30.1 | 9.71 | 4.8 | 10.2 | 5.03 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 2.35 | -3.45 | 0.464 | 0.769 | 0.363 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Cash from Operating Activities | -26.6 | -26.4 | -21.7 | -17.3 | -4.76 |
| Capital Expenditures | -0.087 | -0.542 | -0.168 | -0.186 | 0 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 0 | — | — | — | — |
| Sale of Fixed Assets | |||||
| Cash from Investing Activities | -0.087 | -0.542 | -0.168 | -0.186 | 0 |
| Financing Cash Flow Items | 10.6 | 0 | — | 1.97 | — |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 42.8 | 10.3 | 10.6 | 17.3 | 4.71 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 16.2 | -16.6 | -11.3 | -0.167 | -0.048 |